Correction to Lancet Glob Health 2021; 9: e366–71

Taylor MM, Kobeissi L, Kim C, et al. Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action. Lancet Glob Health 2021; 9: e366–71—In this Health Policy paper, the first sentence of the panel in the section on Interferon beta should have read “Interferon beta has been used to treat multiple sclerosis in pregnant women” and the last two sentences should have read “Although interferon beta drugs are classified as pregnancy category C, the potential benefits could outweigh risks, as noted from published evidence of use in pregnant women”. Some of the referencing in this panel has also been corrected. These corrections have been made as of April 14, 2021.